Inventor · disambiguated record
Shu Wu
Also filed as: WU SHU · WU SHU-FANG
21 granted patents·21 pending applications·85 citations·filing 1998–2023
93Inventor score
Files withNANJING LEGEND BIOTECH CO LTD29LEGEND BIOTECH IRELAND LTD5VANGUARD INT SEMICONDUCT CORP4ELITE SEMICONDUCTOR ESMT2NANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP1
Top patents by PatentIndex Score
42 records- 0185US9090994B2Antibody humanization by framework assemblyZHANG JIANBING·Filed 2012·Granted Jul 28, 2015·9 cites·12 claims
- 0284US11673954B2Single-domain antibodies and variants thereof against PD-L1NANJING LEGEND BIOTECH CO LTD·Filed 2018·Granted Jun 13, 2023·3 cites·19 claims
- 0383US11447573B2Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Sep 20, 2022·3 cites·19 claims
- 0479US11905327B2Single-domain antibodies and variants thereof against TIGITNANJING LEGEND BIOTECH CO LTD·Filed 2018·Granted Feb 20, 2024·1 cites·18 claims
- 0579US11472881B2Single-domain antibodies and variants thereof against CTLA-4NANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Oct 18, 2022·2 cites·21 claims
- 0678US12097219B2Single-domain antibodies against CLL1 and constructs thereofLEGEND BIOTECH IRELAND LTD·Filed 2019·Granted Sep 24, 2024·2 cites·21 claims
- 0777US6392468B1Electrically programmable fuseVANGUARD INT SEMICONDUCT CORP·Filed 2000·Granted May 21, 2002·24 cites·3 claims
- 0875US11958903B2Single-domain antibodies against LAG-3 and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Granted Apr 16, 2024·1 cites·23 claims
- 0974US12168688B2Antibodies and variants thereof against PD-L1NANJING LEGEND BIOTECH CO LTD·Filed 2018·Granted Dec 17, 2024·1 cites·21 claims
- 1074US2024124580A1Single-domain antibodies and variants thereof against tigitNANJING LEGEND BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1173US10407508B2Compositions and methods for increasing protein half-life in a serumNANJING LEGEND BIOTECH CO LTD·Filed 2014·Granted Sep 10, 2019·2 cites·30 claims
- 1272US7236038B2Pulse generator and method for pulse generation thereofELITE SEMICONDUCTOR ESMT·Filed 2005·Granted Jun 26, 2007·7 cites·23 claims
- 1367US12275788B2Single-domain antibodies against CD33 and constructs thereofLEGEND BIOTECH IRELAND LTD·Filed 2019·Granted Apr 15, 2025·0 cites·18 claims
- 1466US2023059836A1Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1563US11932698B2Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Granted Mar 19, 2024·0 cites·24 claims
- 1663US11168146B2Compositions and methods for increasing protein half-life in a serumNANJING LEGEND BIOTECH CO LTD·Filed 2019·Granted Nov 9, 2021·0 cites·20 claims
- 1763US6285238B1Electrically programmable fuseVANGUARD INT SEMICONDUCT CORP·Filed 2000·Granted Sep 4, 2001·10 cites·5 claims
- 1859US2025297029A1Anti-gpc3 chimeric antigen receptor and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 1958US12421292B2Anti-DLL3 chimeric antigen receptors and uses thereofLEGEND BIOTECH IRELAND LTD·Filed 2020·Granted Sep 23, 2025·0 cites·6 claims
- 2058US2025082754A1Anti-cd33 antibodies and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 2157US2025082681A1Antibodies against cll1 and constructs thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 2257US2024279318A1Antibodies targeting afp peptide/mhc complexes and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 2355US2024350545A1Modified immune cells expressing tlr receptorsLEGEND BIOTECH IRELAND LTD·Filed 2022·Application pending·0 cites
- 2455US2024209050A1Mutant il-15 compositions and methods thereofLEGEND BIOTECH IRELAND LTD·Filed 2022·Application pending·0 cites
- 2554US2023226181A1GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPYNANJING LEGEND BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2654US2024150456A1Engineered immune cells and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 2754US2024041924A1T cell and antigen-presenting cell engagers and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2853US2023149461A1Compositions and methods for reducing graft rejection in allogeneic cell therapyNANJING LEGEND BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 2952US2023338422A1Engineering gamma delta t cells with interleukin-36 for immunotherapyNANJING LEGEND BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 3052US2024180964A1Chimeric cytokine receptors and uses thereof in cellular therapiesNANJING LEGEND BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 3150US11713353B2Single-domain antibodies and variants thereof against PD-1NANJING LEGEND BIOTECH CO LTD·Filed 2019·Granted Aug 1, 2023·0 cites·16 claims
- 3250US6100746AElectrically programmable fuseVANGUARD INT SEMICONDUCT CORP·Filed 1998·Granted Aug 8, 2000·14 cites·4 claims
- 3350US2022265709A1Engineered cells and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 3449US11505601B2Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serumNANJING LEGEND BIOTECH CO LTD·Filed 2017·Granted Nov 22, 2022·0 cites·14 claims
- 3548US2022144960A1Cd30-binding moieties, chimeric antigen receptors, and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 3648US2023144237A1Engineered cells and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 3747US2021070855A1Anti-cd47 antibodies that do not cause significant red blood cell agllutinationNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 3847US2022096547A1Modified immune cells expressing flagellin polypeptideNANJING LEGEND BIOTECH CO LTD·Filed 2020·Application pending·0 cites
- 3945US2020369770A1Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 4037US7253666B2Clock frequency divider circuit and method of dividing clock frequencyELITE SEMICONDUCTOR ESMT·Filed 2005·Granted Aug 7, 2007·0 cites·20 claims
- 4136US6110767AReversed MOSVANGUARD INT SEMICONDUCT CORP·Filed 1998·Granted Aug 29, 2000·6 cites·24 claims
- 4230US2013129727A1Methods and systems for increasing protein stabilityNANJINGJINSIRUI SCIENCE & TECHNOLOGY BIOLOGY CORP·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shu Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →